SANCTURA
Commercial- Indications
- Overactive bladder
Company intelligence / Profile preview
Indevus Pharmaceuticals
Lexington, Massachusetts, United Statestechcouncilventures.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Prior to its acquisition by Endo Pharmaceuticals in March 2009, Indevus had a robust portfolio focused on urology and endocrinology with several FDA-approved products on the market for overactive bladder, prostate cancer, and central precocious puberty. The company was also pursuing regulatory approval for drugs targeting male hypogonadism and bladder cancer. Its pipeline included both proprietary small molecules and novel drug-delivery systems.[1][2]
- Therapeutic areas
- OncologyMen's HealthEndocrinologyUrology
- Modalities
- Small molecules[2]Drug-delivery implants[3]Biodegradable stents[3]
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Not specifically detailed in search results.
Beyond the preview
Go deeper on Indevus Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Indevus Pharmaceuticals.